Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protocol for an Randomised Controlled Trial of Smoking Cessation Success Rate With or Without a Genetic Test, "Respiragene", to Assess Lung Cancer Risk - an Exploratory Study

NCT01176383 is registered in ClinicalTrials.gov with Sussex NHS Research Consortium as lead sponsor.

NCT NCT01176383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01176383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protocol for an Randomised Controlled Trial of Smoking Cessation Success Rate With or Without a Genetic Test, "Respiragene", to Assess Lung Cancer Risk - an Exploratory Study
Lead sponsor
Sussex NHS Research Consortium
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
March 31, 2013
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation